TerrAscend Corp. (TSX:TSND)
0.8100
0.00 (0.00%)
Aug 14, 2026, 3:59 PM EST
TerrAscend Market Cap
TerrAscend has a market cap or net worth of CAD 250.43 million as of August 14, 2026. Its market cap has decreased by -32.97% in one year.
Market Cap
250.43M
Enterprise Value
542.86M
Revenue
374.77M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.81
ChartMarket Cap Chart
Since May 3, 2017, TerrAscend's market cap has increased from 35.38M to 250.43M, an increase of 607.89%. That is a compound annual growth rate of 23.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 250.43M | -16.86% |
| Dec 31, 2025 | 301.20M | 12.48% |
| Dec 31, 2024 | 267.77M | -57.63% |
| Dec 29, 2023 | 632.00M | 57.35% |
| Dec 30, 2022 | 401.64M | -72.92% |
| Dec 31, 2021 | 1.48B | -24.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 3, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cresco Labs | 394.69M |
| Cipher Pharmaceuticals | 358.61M |
| Aurora Cannabis | 343.12M |
| Auxly Cannabis Group | 327.28M |
| Organigram Global | 250.58M |
| Cardiol Therapeutics | 244.38M |
| Cannara Biotech | 193.61M |
| Medexus Pharmaceuticals | 170.02M |